Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.
The shares, priced at $17.89, bring the total transaction to $83,277. According to a report from investing.com, the sale was done to meet tax withholding obligations related to the settlement of restricted stock.
Ms. Andrews now has 28,312 shares of Orthofix stock.
In its most recent quarterly report, Orthofix saw $196.6 million in sales.